Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02740660 · ClinicalTrials.gov registry record · NA
Body Composition Changes With Albuterol and Caffeine Versus Placebo in Adolescents
A NA study, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT02740660 is a NA study that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 12 participants.
The verdict
NCT02740660, a NA study, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether taking a combination of caffeine and albuterol three times per day will increase muscle and decrease fat in your child's body and to determine how these medications make your child feel. Albuterol is approved by the FDA for the treatment of asthma. It is not approved to increase muscle and decrease body fat in children.
Interventions
- DRUG Placebo
- DRUG Caffeine 100mg / Albuterol 4mg
- BEHAVIORAL Family weight management counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2016-04 |
| Est. Completion | 2017-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02740660
The ClinicalTrials.gov registry entry for NCT02740660 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT02740660 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02740660 about?
NCT02740660 is a clinical study titled "Body Composition Changes With Albuterol and Caffeine Versus Placebo in Adolescents". The purpose of this study is to determine whether taking a combination of caffeine and albuterol three times per day will increase muscle and decrease fat in your child's body and to determine how these medications make your child feel. Albuterol is approved by the FDA for the treatment of asthma. I...
What is the current status of trial NCT02740660?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2016-04. Estimated completion is 2017-10-31.
What interventions are being tested in trial NCT02740660?
The interventions under investigation include: Placebo (DRUG), Caffeine 100mg / Albuterol 4mg (DRUG), Family weight management counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT02740660?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.